RxDoctor Payments Data

Claudia Lama von Buchwald, MD

Interventional Cardiology · Billings, MTNPI 1447636451

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (50.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 58.5% of the total. Reporting peaked in 2022 at $15,676 and has fallen 85.8% since, to $2,222 in 2025.

$29,496in general payments, 2019–2025

Across 125 payments — averaging $235.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$17K
  • Penumbra, Inc.$4K
  • Abbott$3K
  • Edwards Lifesciences$3K
  • Boston Scientific$711
  • Shockwave Medical, Inc$324
  • plus $942 from 10 others

What the payments were for

  • Grants$15,00051%
  • Travel & lodging$7,65826%
  • Food & beverage$6,55822%
  • Education$2801%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,496 in reported general payments places this provider in the 75th percentile of 22 interventional cardiology providers in Montana.

See all interventional cardiology providers in Montana

Medicare billing

Part B allowed, 2024
$244,153
Medicare patients
666
Services billed
1,696

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$106,708
FarxigaDapagliflozin Propanediol30$22,867
XareltoRivaroxaban24$15,055
JardianceEmpagliflozin12$14,527
Repatha SureclickEvolocumab17$9,924
Repatha SyringeEvolocumab11$5,011
Metoprolol Succinate163$2,260
Atorvastatin Calcium169$1,570
Bumetanide28$1,343
Ezetimibe38$1,028
ClopidogrelClopidogrel Bisulfate86$952
Losartan Potassium109$644
Potassium Chloride26$598
Furosemide90$448
Carvedilol59$405

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →